Levodopa
Ended Awarded Last action
- Contract number
- 36C77026N0018
- Awardee
-
Merz Pharmaceuticals, LLC UEI UMD1NK9KU143
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $709,836
Award facts
- Contract value 100% obligated
- $709,836.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Raleigh, NC 27615, USA
Award details come from SAM.gov/FPDS.
About this award
Merz Pharmaceuticals, LLC was awarded a delivery order valued at $709,836.48 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, for the supply of Levodopa pharmaceutical products. The contract, awarded on March 9, 2026, with a completion date of March 20, 2026, operates under a firm fixed-price structure with no set-aside designation. Performance will take place in Raleigh, North Carolina. This delivery order is issued under the GSA Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs, leveraging Merz Pharmaceuticals' pre-established pricing and terms for efficient federal procurement.
Merz Pharmaceuticals, a foreign-owned pharmaceutical company registered in the System for Award Management since October 2012, holds a substantial Blanket Purchase Agreement with the National Acquisition Center under the same GSA pharmaceutical schedule, with a ceiling value of $12.06 million through March 2026. The company specializes in providing critical pharmaceutical supplies to federal healthcare institutions, including veteran facilities and military medical systems. This particular award supports VISN 12's mission to deliver healthcare services to veterans across its network, ensuring access to Levodopa—a medication used in treating Parkinson's disease and related neurological conditions.
Quick answers
Who was awarded contract 36C77026N0018?
36C77026N0018 was awarded to Merz Pharmaceuticals, LLC by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 9, 2026.
How much is contract 36C77026N0018 worth?
The government has obligated $709,836 on 36C77026N0018.
Which agency awarded contract 36C77026N0018?
Veterans Integrated Service Network 15 (Veterans Health Administration) awarded 36C77026N0018, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).
Is contract 36C77026N0018 an order under another contract?
Yes. 36C77026N0018 is a delivery order under 36F79719D0246, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C77026N0018 competed?
The extent of competition for 36C77026N0018 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award